Venture
Bluejay Therapeutics, Inc.
Latest Form D 2024-05-10- CIK 1868267
- State CA
- Other Technology
- 3 Form D offerings since 2021-06-21
- Total sold
- $222M
- across 3 offerings
- Rounds
- 3
- Form D offerings since 2021-06-21
- Latest round
- $182M
- 2024-05-10 · 021-512955
- Investors
- 19
- on the latest round
Connected
named in its Form D filingsOfferings · since 2021-06-213 Form D offeringsExemptions506(b)People · Item 3Keting Chu + 5 moreInvestors · dashboard1 inferred investor
Bluejay Therapeutics, Inc.CIK 1868267
Round timeline
amount sold · by first filed2024-05-10 · $182M
- 2021-06-21$19.2M021-403422
- 2022-08-16$20.5M021-456062
- 2024-05-10$182M021-512955
Hover a dot or row, or tab through the dots · bars scaled to the largest round ($182M)
Form D offerings
One line per offering, amendments folded in, newest first
| File | First filed | Latest | Sought | Sold | Investors | Exemptions |
|---|---|---|---|---|---|---|
| 021-512955 | First filed2024-05-10 | Latest2024-05-10 | Sought$182M | Sold$182M | Investors19 | Exemptions506(b) |
| 021-456062 | First filed2022-08-16 | Latest2022-08-16 | Sought$41.2M | Sold$20.5M | Investors9 | Exemptions506(b) |
| 021-403422 | First filed2021-06-21 | Latest2021-06-21 | Sought$24.2M | Sold$19.2M | Investors6 | Exemptions506(b) |
Who backs Bluejay Therapeutics, Inc. — 1 inferred investor — and every Form D as filedSee plans
People
Named in Item 3 of its latest Form D, filed 2024-05-10
| Name | Relationship |
|---|---|
| Keting Chu | RelationshipExecutive Officer, Director |
| Pascal Krotee | RelationshipDirector |
| Alon Lazarus | RelationshipDirector |
| Dajun Yang | RelationshipDirector |
| Jianqing Li | RelationshipDirector |
| Dan Estes | RelationshipDirector |
Facts
As its latest Form D states them
- Industry
- Other Technology
- State
- California (CA)
- Exemptions
- Rule 506(b)
- First filed
- 2021-06-21
- Latest filing
- 2024-05-10
Who backs Bluejay Therapeutics, Inc.
Form D names a startup's officers and directors, not its investors. The dashboard infers them — the venture funds whose own filings and people overlap this company's rounds — and lays every Form D and amendment it filed beside the totals above.
- Inferred investors — the funds and firms behind it, from co-filings and shared people
- Every Form D and amendment as filed, with what each one stated
- Its rounds in sequence: the gap between them and whether they grew
- Everyone its filings name, linked to their other companies, with its addresses and phone numbers
Part of the Venture plan — $140/mo at launch pricing ($350 list)
See plansExternal link: SEC Filings ↗